Favorable effect of corticosteroids in treating acute-onchronic liver failure underlying chronic hepatitis B
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Acute-on-chronic liver failure (ACLF) occurs in the presence of a chronic liver disease or cirrhosis, and often results from exacerbation of chronic hepatitis B (CHB). The efficacy of corticosteroid treatment in ACLF patients with underlying CHB remains unclear. We report the case of a 50-year-old woman who experienced ACLF due to CHB exacerbation and was treated with a combination of corticosteroids and nucleot(s)ide analogue (NUC). The patient showed rapid decompensation due to CHB exacerbation. Three months of antiviral therapy produced no improvement in liver function. Combination therapy with corticosteroids and NUC was started, which did result in improvement of liver function. This case shows that the combined therapy of corticosteroids and NUC can be effective in treating ACLF due to CHB exacerbation.
Abstract
Acute-on-chronic liver failure (ACLF) occurs in the presence of a chronic liver disease or cirrhosis, and often results from exacerbation of chronic hepatitis B (CHB). The efficacy of corticosteroid treatment in ACLF patients with underlying CHB remains unclear. We report the case of a 50-year-old woman who experienced ACLF due to CHB exacerbation and was treated with a combination of corticosteroids and nucleot(s)ide analogue (NUC). The patient showed rapid decompensation due to CHB exacerbation. Three months of antiviral therapy produced no improvement in liver function. Combination therapy with corticosteroids and NUC was started, which did result in improvement of liver function. This case shows that the combined therapy of corticosteroids and NUC can be effective in treating ACLF due to CHB exacerbation.
참고문헌 (18)
- Sarin SK, "Acute-on-chronic liver failure: terminology, mechanisms and management", Nat Rev Gastroenterol Hepatol, 13, pp.131~149 (2016)
- Yasui S, "Virological efficacy of combination therapy with corticosteroid and nucleoside analogue for severe acute exacerbation of chronic hepatitis B", J Viral Hepat, 22, pp.94~102 (2015)
- Fujiwara K, "The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B", J Gastroenterol, 45, pp.1255~1262 (2010)
- Chisari FV, "Hepatitis B virus immunopathogenesis", Annu Rev Immunol, 13, pp.29~60 (1995)
- Sjogren MH, "Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitis", Hepatology, 7, pp.582~585 (1987)
- Levy P, "Clinical course of spontaneous reactivation of hepatitis B virus infection in patients with chronic hepatitis B", Hepatology, 12, pp.570~574 (1990)
- Garg H, "Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure", Hepatology, 53, pp.774~780 (2011)
- Fujiwara K, "Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis B", J Gastroenterol, 43, pp.711~719 (2008)
- Zhang XQ, "Efficacy of short-term dexamethasone therapy in acute-on-chronic pre-liver failure", Hepatol Res, 41, pp.46~53 (2011)
- He B, "Glucocorticoids can increase the survival rate of patients with severe viral hepatitis B : a meta-analysis", Eur J Gastroenterol Hepatol, 25, pp.926~934 (2013)
- Cheng AL, "Steroid-free chemotherapy decreases risk of hepatitis B virus(HBV)reactivation in HBV-carriers with lymphoma", Hepatology, 37, pp.1320~1328 (2003)
- Wu CY, "Lymphocyte", monocyte ratio and cycles of rituximab-containing therapy are risk factors for hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma and resolved hepatitis B, 2015, pp.56, 2357~2364
- Chemin I, "Role of silent hepatitis B virus in chronic hepatitis B surface antigen(-)liver disease", Antiviral Res, 52, pp.117~123 (2001)
- Wong VW, "Entecavir treatment in patients with severe acute exacerbation of chronic hepatitis B", J Hepatol, 54, pp.236~242 (2011)
- Ware A, "A prospective trial of steroid therapy in severe viral hepatitis. The prognostic significance of bridging necrosis", Gastroenterology, 80, pp.219~224 (1981)
- Gregory PB, "randomized trial of methylprednisolone versus placebo", N Engl J Med, 294, pp.681~687 (1976)
- O’Leary JG, "De novo autoimmune hepatitis during immune reconstitution in an HIV-infected patient receiving highly active antiretroviral therapy", Clin Infect Dis, 46, pp.e12~e14 (2008)
- Murunga E, "Autoimmune hepatitis: a manifestation of immune reconstitution inflammatory syndrome in HIV infected patients?", Scand J Gastroenterol, 51, pp.814~818 (2016)